Who owns BioMarin?
BioMarin Pharmaceutical
| Type | Public |
|---|---|
| Founded | March 1997 |
| Founders | Christopher Starr, Ph.D. Grant W. Denison Jr. |
| Headquarters | San Rafael, California, U.S. |
| Key people | Jean-Jacques Bienaimé (Chairman & CEO) Daniel Spiegelman (Executive VP & CFO) Brian R. Mueller (Senior VP, Finance & CAO) |
What does BioMarin Pharmaceutical Inc do?
BioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions.
What drugs does BioMarin make?
Our Products
- VOXZOGO™ (vosoritide)
- PALYNZIQ® (pegvaliase-pqpz) Injection.
- Brineura® (cerliponase alfa)
- Vimizim® (elosulfase alfa)
- Kuvan® (sapropterin dihydrochloride)
- Naglazyme® (galsulfase)
- Aldurazyme® (laronidase)
Is BioMarin a good place to work?
BioMarin Pharmaceutical is ranked #32 on the Best Health Care Companies to Work For in California list. Zippia’s Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
Where is BioMarin headquarters?
Novato, CA
BioMarin Pharmaceutical/Headquarters
Is BioMarin a Fortune 500 company?
BioMarin Pharmaceutical | 2021 Fortune 500 | Fortune.
Where is BioMarin pharmaceutical located?
San Rafael
Our headquarters and original manufacturing facilities are located just north of San Francisco in Marin County. Located in downtown San Rafael, our corporate headquarters has a campus-like feel with multiple buildings joined by meandering green walkways with the San Francisco Bay and Mount Tamalpais in the background.
How many locations does BioMarin have?
BioMarin Pharmaceutical is headquartered in San Rafael, CA and has 34 office locations across 20 countries.
What BMN 111?
BMN 111: An investigational therapy developed by BioMarin. Currently in clinical trials, BMN 111 may work on the underlying problem to signal regular bone growth. OUR GOAL: To give individuals with achondroplasia an option to reduce the impact of these complications on their lives.
When was biobiomarin founded?
BioMarin was founded in 1997 by Christopher Starr Ph.D. and Grant W. Denison Jr. with an investment of a $1.5 million from Glyko Biomedical and went public in 1999.
What is BioMarin Pharmaceutical Inc’s market cap?
Market Cap $15.6B BioMarin Pharmaceutical, Inc. engages in the development and commercialization of innovative pharmaceuticals for serious diseases and medical conditions. It operates its business through one segment, the biopharmaceutical development and commercialization segment. Its company’s products include Naglazyme, Kuvan,…
What is BioMarin’s core business and research?
BioMarin’s core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I), by manufacturing laronidase ( Aldurazyme, commercialized by Genzyme Corporation). BioMarin was also the first company to provide therapeutics for phenylketonuria ( PKU ).
Why is BioMarin so controversial?
Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials. BioMarin was founded in 1997 by Christopher Starr Ph.D. and Grant W. Denison Jr. with an investment of a $1.5 million from Glyko Biomedical and went public in 1999.